A review of the psychometric properties of generic utility measures in multiple sclerosis
- PMID: 24846760
- DOI: 10.1007/s40273-014-0167-5
A review of the psychometric properties of generic utility measures in multiple sclerosis
Abstract
Objective: The reliability and validity of generic utility measures have not yet been summarized in people with multiple sclerosis (MS). It is important to assess the psychometric properties of these measures, to ensure that the values obtained by the scoring system are valid for interpretation and utilization by clinicians, researchers and policy makers. Therefore, the objective of this review was to summarize the evidence from published literature on the psychometric properties of generic utility measures in MS.
Methods: A structured literature search was conducted by using multiple electronic databases. All potentially relevant abstracts and full-text articles were read to identify publications that may be eligible for inclusion in the review. A meta-analysis was conducted to combine correlation coefficient values for convergent validity. The Schmidt-Hunter method, a weighted mean of the correlation coefficient values, was used. Heterogeneity, the percentage of total variation across studies that is due to between-study differences rather than chance, was assessed using the I (2) statistic.
Results: The following generic utility measures were identified: the EQ-5D (n = 9)/EQ-5D-5 Level (EQ-5D-5L) (n = 1), followed by the Health Utilities Index Mark 3/2 (HUI2/HUI3) (n = 3), the SF-6D (n = 2), the Assessment of Quality of Life (AQOL) (n = 2), and the Quality of Well-Being (QWB) scale (n = 1). Ceiling and floor effects were present for the EQ-5D and the SF-6D, but not for the HUI3. The EQ-5D, the SF-6D and the HUI3 demonstrated excellent reliability. In terms of discriminative ability, the SF-6D and the QWB scale were not able to differentiate between moderately and severely disabled MS patients, and the EQ-5D was not able to differentiate between those who were mildly and moderately disabled. The AQOL and the HUI3, on the other hand, demonstrated good discriminative ability, as both measures were able to differentiate between all levels of disability. As for convergent validity, the HUI2/HUI3 were highly correlated (r = 0.7) against measurement instruments that evaluated impairments such as disease severity, ambulation and manual dexterity. The EQ-5D, SF-6D and the QWB scale demonstrated small to moderate correlations (r = 0.4) against instruments evaluating impairments, and slightly stronger correlations against measures of activity limitations/participation restrictions and health-related quality of life (HRQL) (r = 0.6).
Conclusion: To our knowledge this is the first study to review the validity and reliability of generic utility measures in MS. The HUI3 demonstrated the strongest psychometric properties when compared with other utility measures. However, the HUI3 only measures impairment and excludes important components of HRQL such as participation restrictions. The EQ-5D, the SF-6D and the QWB scale, on the other hand, do include items on participation. However, these measures demonstrated a lack of content validity in MS by missing certain domains that were important to the disease, as well as difficulty in differentiating between different levels of disability. The addition of MS-specific 'bolt-ons' to generic utility measures and the development of an MS specific utility measure are possible areas of exploration for future research.
Similar articles
-
Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.Health Technol Assess. 2014 Feb;18(9):1-224. doi: 10.3310/hta18090. Health Technol Assess. 2014. PMID: 24524660 Free PMC article. Review.
-
Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?Health Qual Life Outcomes. 2013 Apr 25;11:71. doi: 10.1186/1477-7525-11-71. Health Qual Life Outcomes. 2013. PMID: 23618072 Free PMC article.
-
A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.J Med Econ. 2022 Jan-Dec;25(1):829-839. doi: 10.1080/13696998.2022.2087409. J Med Econ. 2022. PMID: 35674412
-
A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.Soc Sci Med. 2005 Apr;60(7):1571-82. doi: 10.1016/j.socscimed.2004.08.034. Soc Sci Med. 2005. PMID: 15652688
-
EQ-5D in skin conditions: an assessment of validity and responsiveness.Eur J Health Econ. 2015 Dec;16(9):927-39. doi: 10.1007/s10198-014-0638-9. Epub 2014 Oct 31. Eur J Health Econ. 2015. PMID: 25358263 Free PMC article. Review.
Cited by
-
Improving the efficiency of clinical trials in multiple sclerosis.Mult Scler. 2023 Aug;29(9):1136-1148. doi: 10.1177/13524585231189671. Mult Scler. 2023. PMID: 37555492 Free PMC article. Review.
-
Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand.Eur J Health Econ. 2023 Aug;24(6):939-950. doi: 10.1007/s10198-022-01518-x. Epub 2022 Sep 23. Eur J Health Econ. 2023. PMID: 36149605 Free PMC article.
-
Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia.Qual Life Res. 2023 Feb;32(2):553-568. doi: 10.1007/s11136-022-03214-y. Epub 2022 Aug 29. Qual Life Res. 2023. PMID: 36036311 Free PMC article.
-
Measurement properties of the EQ-5D in populations with a mean age of ≥ 75 years: a systematic review.Qual Life Res. 2023 Feb;32(2):307-329. doi: 10.1007/s11136-022-03185-0. Epub 2022 Aug 1. Qual Life Res. 2023. PMID: 35915354 Free PMC article. Review.
-
The effect of nurse practitioner (NP-led) care on health-related quality of life in people with multiple sclerosis - a randomized trial.BMC Neurol. 2022 Jul 25;22(1):275. doi: 10.1186/s12883-022-02809-9. BMC Neurol. 2022. PMID: 35879701 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials